JAMA Cardiology
Original Investigation
April 17, 2024
YiÌýLi,ÌýMD; JingÌýLi,ÌýMD; BinÌýWang,ÌýMD; QuanminÌýJing,ÌýMD; YujieÌýZeng,ÌýMD; AijieÌýHou,ÌýMD; ZhifangÌýWang,ÌýMD; AijunÌýLiu,ÌýMD; JinliangÌýZhang,ÌýMD; YaojunÌýZhang,ÌýMD; PingÌýZhang,ÌýMD; DamingÌýJiang,ÌýMD; BinÌýLiu,ÌýMD; JiamaoÌýFan,ÌýMD; JunÌýZhang,ÌýMD; LiÌýLi,ÌýMD; GuohaiÌýSu,ÌýMD; MingÌýYang,ÌýMD; WeihongÌýJiang,ÌýMD; PengÌýQu,ÌýMD; HesongÌýZeng,ÌýMD, PhD; LuÌýLi,ÌýMD; MiaohanÌýQiu,ÌýMD; LeishengÌýRu,ÌýMD; ShaoliangÌýChen,ÌýMD; YujieÌýZhou,ÌýMD; ShubinÌýQiao,ÌýMD; Gregg W.ÌýStone,ÌýMD; Dominick J.ÌýAngiolillo,ÌýMD, PhD; YalingÌýHan,ÌýMD; OPT-BIRISK Investigators
online first
JAMA Cardiol. 2024; 10.1001/jamacardio.2024.0534
This randomized clinical trial evaluates clopidogrel monotherapy vs dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions who are at high bleeding and ischemic risk.
JAMA
Original Investigation
October 24, 2023
YuejinÌýYang,ÌýMD, PhD; XiangdongÌýLi,ÌýMD, PhD; GuihaoÌýChen,ÌýMD, PhD; YingÌýXian,ÌýMD, PhD; HaitaoÌýZhang,ÌýMD, PhD; YuanÌýWu,ÌýMD; YanminÌýYang,ÌýMD; JianhuaÌýWu,ÌýMD; ChuntongÌýWang,ÌýMD; ShenghuÌýHe,ÌýMD; ZhongÌýWang,ÌýMD; YixinÌýWang,ÌýMD; ZhifangÌýWang,ÌýMD; HuiÌýLiu,ÌýMD; XipingÌýWang,ÌýMD; MinzhouÌýZhang,ÌýMD; JunÌýZhang,ÌýMD, PhD; JiaÌýLi,ÌýMD; TaoÌýAn,ÌýMD; HaoÌýGuan,ÌýMD; LinÌýLi,ÌýMD; MeixiaÌýShang,ÌýMD; ChenÌýYao,ÌýMD; YalingÌýHan,ÌýMD, PhD; BoliÌýZhang,ÌýMD; RunlinÌýGao,ÌýMD; Eric D.ÌýPeterson,ÌýMD, MPH; CTS-AMI Investigators
free access
JAMA. 2023; 330(16):1534-1545. 10.1001/jama.2023.19524
This randomized clinical trial assesses the efficacy of Tongxinluo, a traditional Chinese medicine compound, vs placebo in improving clinical outcomes in patients with ST-segment elevation myocardial infarction.